Business Context and Reporting Period
Company: Addus HomeCare Corp (ADUS)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 2024
Business Overview: Addus operates three segments: Personal Care, Hospice, and Home Health. As of December 31, 2024, the company served approximately 105,000 discrete consumers across 23 states through approximately 258 offices. The company primarily serves "dual-eligible" consumers (Medicare and Medicaid) and relies heavily on government payors and managed care organizations.
Key Financial Metrics
| Metric | 2024 | 2023 | Change |
|---|---|---|---|
| Net Service Revenues | $1,154.6 million | $1,058.7 million | +9.1% |
| Net Income | $73.6 million | $62.5 million | +17.7% |
| Operating Income | $102.7 million | $91.0 million | +12.9% |
| Adjusted EBITDA | $140.3 million | $121.0 million | +16.0% |
| Gross Margin | 32.5% | 32.1% | +0.4 pts |
| Total Assets | $1,412.6 million | $1,024.4 million | +38.0% |
| Cash and Equivalents | $98.9 million | $64.8 million | +52.6% |
| Revolving Debt Outstanding | $223.0 million | $126.4 million | +76.4% |
| Available Borrowing Capacity | $346.6 million | $335.6 million | +3.3% |
Material Changes vs. Prior Period
- Revenue Growth: Driven by a 7.8% increase in Personal Care, 10.2% in Hospice, and 23.0% in Home Health. Personal Care growth was fueled by a 5.2% increase in revenue per billable hour and a 2.1% increase in billable hours.
- Acquisitions: The company completed two major acquisitions in 2024:
- Gentiva Acquisition (Dec 2, 2024): Purchased for approx. $353.6 million, expanding Personal Care into Arizona, Arkansas, California, North Carolina, Missouri, and Texas, and Home Health in Tennessee.
- Upstate Home Care Solutions (Mar 9, 2024): Purchased for $0.4 million, expanding Personal Care in South Carolina.
- Divestiture: Sold New York operations (New York Asset Sale) for up to $23.0 million, recording a $3.7 million gain on divestiture in Q4 2024.
- Capital Markets: Completed a public offering of 1.725 million shares in June 2024, raising net proceeds of $175.6 million. Approximately $81.4 million was used to repay debt.
- Profitability: Net income margin improved to 6.4% from 5.9%. Operating expenses increased 9.4%, primarily due to the full-year impact of the 2023 Tennessee Quality Care acquisition and higher administrative costs.
Guidance, Outlook, Risks, and Unusual Items
Management Commentary and Outlook
Management expects continued growth driven by an aging population and the shift toward home-based care. The company is focusing on organic growth in existing markets and strategic acquisitions to expand its footprint in states with favorable demographics and managed care environments. The Gentiva acquisition is expected to significantly increase revenue concentration in Texas.
Key Risks and Contingencies
- Payor Concentration: Illinois represents 43.7% of total revenue. The Illinois Department on Aging alone accounted for 21.0% of total revenue. Changes in state funding or reimbursement rates pose a significant risk.
- Regulatory Changes: The company faces risks from the CMS "80/20" rule (requiring 80% of Medicaid payments to go to direct care worker compensation by 2030), potential Medicaid block grants, and changes in Medicare Advantage policies.
- Labor Market: High competition for caregivers and rising minimum wage laws (e.g., Illinois, Chicago) increase operating costs. 34.8% of the workforce is unionized.
- Reimbursement Delays: Timing differences in government reimbursements can impact liquidity. Days Sales Outstanding (DSO) remained stable at 39 days.
Unusual Items
- Impairment Charges: Recorded $5.0 million in impairment charges on operating lease assets related to the New York divestiture and sublease expiration.
- Gain on Divestiture: Recognized a $3.7 million gain from the sale of New York operations.
Investor Verification Checklist
- Illinois Exposure: Verify the stability of the Illinois Department on Aging contract and the impact of the 2025 rate increase ($29.63/hr) versus rising minimum wage requirements.
- Gentiva Integration: Assess the integration progress of the Gentiva acquisition (closed Dec 2024) and its contribution to 2025 revenue, noting it was excluded from the internal control audit.
- Debt Covenants: Confirm compliance with the Total Net Leverage Ratio (max 3.75:1.00) given the increased debt load from the Gentiva acquisition.
- Regulatory Impact: Monitor the implementation timeline and financial impact of the CMS "80/20" payment adequacy rule on Medicaid margins.
- Goodwill Valuation: Review the $970.6 million goodwill balance (up from $663.0 million) for potential impairment triggers given the high acquisition activity.